The expression of the MDR1 gene significantly impacts the pharmacokinetics of drugs. By influencing the absorption and elimination of drugs, P-glycoprotein affects the bioavailability and overall efficacy of therapeutic agents. This has significant implications for drug dosing and the development of drug formulations that can bypass or inhibit P-glycoprotein activity.
